ArticlePediatric surgery international2026
Challenging the size: ovarian-sparing surgery in borderline huge pediatric ovarian tumors.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveHuge ovarian tumors in paediatric patients pose a surgical challenge, particularly in distinguishing tumor margins from ovarian parenchyma. While ovarian preservation is recommended for benign masses, concerns about tumor size may limit its application. This study evaluates the feasibility and outcomes of ovarian-sparing surgery (OSS) in children with giant ovarian tumors. MATERIALS AND
methodsA retrospective study was realize on girls (< 18 years) who underwent surgery for ovarian masses with cystic lesions ≥ 8 cm in our department (2009-2019). We included all patients classified O-RADS 3 and 4, and excluded O-RADS 5 in those OSS is contraindicated. Data on clinical presentation, imaging, tumor characteristics, surgical approach, histopathology, and follow-up were collected. Patients were categorized into two groups: OSS and oophorectomy (OV).
resultsThirty patients (mean age: 13 years, range 3-17) were treated, including one with bilateral tumors. Palpable abdominal mass was the most common symptom (33.3%). The median tumor diameter was 148 mm (range 80-350 mm); 16 were purely cystic, 15 had mixed components, and 4 had calcifications. Tumor markers were negative except in 2 cases. Histology confirmed all tumors were benign (17 teratomas, 12 cystadenomas, 2 functional cysts).
Indexed as
Identifiers
42606737What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.